* THERACLION *
2004 - IDF
Paris
www.theraclion.fr Development, Devices
Key words: Ultrasound, Parathyroidism, Prostate cancer, UNIS
Mission: to develop non-invasive solutions, based on High Intensity Focussed Ultrasound (HiFu), for the treatment of secondary hyperparathyroidism and thyroid nodules
Clients: undisclosed
ismael@theraclion.fr
Age: 7 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS |
|---|
| Start-up |
Managing Dir.-CEO: Nujurally (Ismaël) [born 1957, M.D., ex-Abbott, Bard, American Medical Systems, Tyco, Oxford Instruments]
Sc.Dir.-CSO: Lacoste (François) [co-founder, born 1950, Eng. physics, ex-Technomed, Cilas-Alacatel, Perkin Elmer]
R&D Dir.-CMO: Yon (Sylvain) [born 1974, ESCPI, Ph.D. physics, ex-Echosens (co-founder)]
Fin.Dir.-CFO:
BusDev: Del Bourgo (David) [Eng. UIT Compiègne, MBA Chicago, ex-Orbotech, Advention Business Partners, General Electric Healthcare]
Financers (Hist.): Truffle Ventures | Turnover (M€) : n.a.
Total funding (M€) : 8.6
Last funding (M€) : 1.6
Focus : Multiple
Position : Clinical
Company confirm : none |
History | DATE | MILESTONE | TYPE | TIME |
|---|
| 2010 .09 | Nomination : Ismaël Nujurally, new CEO, replacing François Lacoste (as CSO) | ORGN | [6 years] |
| 2009 .02 | Financing (no interest loan) : 8.5 M€ (of which 3.5 M€ as grant), OSEO Innovation, as part of the TUCE strategic industrial innovation project on elastography-guided ultrasound therapy | DEBT | [4 years] |
| 2008 .00 | 1st round-financing (follow-up) : 1.6 M€, by Truffle Venture | RFINA | [3 years] |
| 2007 .12 | Financing (no interest loan) : 1.3 M€ from OSEO Innovation (together with CE Mark approval) | DEBT | [3 years] |
| 2006 .03 | Clinical trial (phase II) for a non-invasive treatment of thyroid nodules (beginning) | CLIN | [1 year] |
| 2005 .04 | 1st round-financing : 3.5 M€, by Truffle Venture | RFINA | [0 year] |
| 2004 .08 | Company founded by François Lacoste (CEO), Gérard Hascoët [Promed, Sometec, IMMI, Technomed International], Jean Louis Hervy [Sapex, SMI], Annie Claude Benichou [M.D.], Guillaume Olivier Doré | ORGF | [0 year] | Actualisation / Updating: 23-Sep-2011 |
|
